Dr. Sethi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Brigham and Womens HospitalFellowship, Selective Pathology, 1999 - 2001
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- Assam Medical CollegeClass of 1985
Certifications & Licensure
- MN State Medical License 2005 - 2026
- IA State Medical License 2001 - 2007
- CT State Medical License 1998 - 2001
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Clinicopathologic Characteristics of Crystalglobulin-Induced Nephropathy: A Case Series.Samih H Nasr, Satoru Kudose, Anthony M Valeri, Ali Kashkouli, Samar M Said
American Journal of Kidney Diseases. 2024-12-01 - Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series.Samih H Nasr, Surendra Dasari, Anthony M Valeri, Jason D Theis, Ann Moyer
American Journal of Kidney Diseases. 2024-11-13 - Lupus nephritis: redefining the treatment goals.An S De Vriese, Sanjeev Sethi, Fernando C Fervenza
Kidney International. 2024-11-08
Lectures
- From Classification to Morpho-omic Taxonomies: Moving the Needle to the 21st CenturyAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
Other
- Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)Sethi S, Fervenza FC, Kyle RA, Flamm S
http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-the-mixed-cryoglobulinemia
UpToDate, Wolters Kluwer Health - 2012-09-17 - Evaluation and treatment of membranoproliferative glomerulonephritisSethi S, Fervenza FC
http://www.uptodate.com/contents/evaluation-and-treatment-of-membranoproliferative-glomerulonephriti
UpToDate, Wolters Kluwer Health - 2012-09-12 - Glomerular diseases due to nonamyloid fibrillar depositsSethi S, Fervenza FC, Appel GB
http://www.uptodate.com/contents/glomerular-diseases-due-to-nonamyloid-fibrillar-deposits
UpToDate, Wolters Kluwer Health - 2012-09-04 - Join now to see all
Press Mentions
- Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin DepositsMarch 9th, 2021
- Glomerular Biomarkers – Peering into the FutureFebruary 10th, 2021
- The 2020 Vision for Mayo Clinic ProceedingsJanuary 6th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: